enVVeno Medical Corp (NVNO): Total Liabilities
$2.43M
As of 2025-12-31
$1.99M
As of 2026-06-30
-6.0%
3-year compound annual growth
-6.7%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.43M | -13.0% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $2.79M | +14.8% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $2.44M | -17.0% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $2.93M | -11.0% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $3.29M | -4.2% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $3.44M | +40.7% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $2.44M | +60.5% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $1.52M | -81.4% | 2020-03-18, Balance as of period end |
| 2017-12-31 | $8.17M | n/a | 2019-03-14, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | 2025-12-31 | $2.43M | -13.0% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $11.15M | +7.2% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $11.99M | -40.6% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $11.47M | -32.5% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $26.70M | +264.3% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $4.11M | -57.5% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $69.19M | +38.8% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $29.18M | +85.6% |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $32.08M | +9.5% |
Compare NVNO, KRMD, WOK, IDXG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗